These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20155603)

  • 21. The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017.
    Kurtz SP; Buttram ME; Margolin ZR; Wogenstahl K
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):700-706. PubMed ID: 30909323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a more strict 2014 DEA schedule designation for hydrocodone products on opioid prescription rates in the United States.
    Harrison ML; Walsh TL
    Clin Toxicol (Phila); 2019 Nov; 57(11):1064-1072. PubMed ID: 30789065
    [No Abstract]   [Full Text] [Related]  

  • 23. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
    Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
    Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the abuse of tapentadol immediate release: the first 24 months.
    Dart RC; Cicero TJ; Surratt HL; Rosenblum A; Bartelson BB; Adams EH
    J Opioid Manag; 2012; 8(6):395-402. PubMed ID: 23264317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Volume of prescription opioids used nonmedically in the United States.
    Katz NP; Birnbaum HG; Castor A
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):141-4. PubMed ID: 20504136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Diversion of Prescription Opioid Analgesics.
    Inciardi JA; Surratt HL; Lugo Y; Cicero TJ
    Law Enforc Exec Forum; 2007 Nov; 7(7):127-141. PubMed ID: 25267926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
    Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
    MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription opioid misuse, sources of opioids and reasons for opioid misuse among reproductive aged parenting women with major depressive episode.
    Sanmartin MX; Ali MM; Chen J; Dwyer DS
    Addict Behav; 2019 Nov; 98():106057. PubMed ID: 31376658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sources of prescription opioids among diagnosed opioid abusers.
    Shei A; Rice JB; Kirson NY; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Curr Med Res Opin; 2015 Apr; 31(4):779-84. PubMed ID: 25661018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of prescription medication diversion among drug dealers.
    Rigg KK; Kurtz SP; Surratt HL
    Drugs (Abingdon Engl); 2012; 19(2):144-155. PubMed ID: 22665955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids.
    Chua KP; Brummett CM; Conti RM; Haffajee RL; Prosser LA; Bohnert ASB
    JAMA Netw Open; 2019 May; 2(5):e193673. PubMed ID: 31074819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources.
    Manchikanti L
    Pain Physician; 2006 Oct; 9(4):287-321. PubMed ID: 17066115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wanted: a public health approach to prescription opioid abuse and diversion.
    Joranson DE; Gilson AM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):632-4. PubMed ID: 16862603
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.
    Hulme S; Bright D; Nielsen S
    Drug Alcohol Depend; 2018 May; 186():242-256. PubMed ID: 29626777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nurses' Role in Preventing Prescription Opioid Diversion.
    Manworren RC; Gilson AM
    Am J Nurs; 2015 Aug; 115(8):34-40; quiz 41. PubMed ID: 26186473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abuse of prescription drugs: is a patient ailing or addicted?
    Mitka M
    JAMA; 2000 Mar; 283(9):1126, 1129. PubMed ID: 10703764
    [No Abstract]   [Full Text] [Related]  

  • 40. Patterns of abuse and routes of administration for immediate-release hydrocodone combination products.
    Cassidy TA; Oyedele N; Mickle TC; Guenther S; Budman SH
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1071-1082. PubMed ID: 28771942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.